Granules India

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE101D01020
  • NSEID: GRANULES
  • BSEID: 532482
INR
855.00
-17.45 (-2.0%)
BSENSE

Aug 10

BSE+NSE Vol: 7.76 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 580033,
    "name": "Granules India",
    "stock_name": "Granules India",
    "full_name": "Granules India Ltd",
    "name_url": "stocks-analysis/granules-india",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "855.00",
    "chg": -17.45,
    "chgp": "-2.0%",
    "dir": -1,
    "prev_price": "872.45",
    "mcapval": "21,631.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532482,
    "symbol": "GRANULES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE101D01020",
    "curr_date": "Aug 10",
    "curr_time": "",
    "bse_nse_vol": "7.76 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/granules-india-580033-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Granules Q1 net up 60% at 180 crore",
        "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxOUUNCbi00QlcwYTFJdG9NaXJXXzM2bmxJWkdjQXcxb29XSDIxZEJjX0c2eWVZOG5iblBHeU9BQmk5bDREaHgtdTEwQmx6a1k3bVNNd3NaNG5OU1U5TmJSV1ZnR3JVcTB4bnpmQVM0SEE5REtPWURscU1sQm1NdDQtVjhYZ1JkUTc4RUhHRGEweGIzVTBWYVUwQl9LS0ZHOC1XWjFr0gGqAUFVX3lxTE5ySnhOZUFXVkd1ZHRsdS04VVpsZ0NHem5iLUhUenlZZTVRbG1YS2lhZTVRRGd4bGdrZmluQUF5X0xUVTd2RnZrbDU1VUVyTlozNzBORGRkRm93WmVkWEpFeHJfZTdwQnl0Wnl3X2FmVktGazJqdDctRmNFR1oyMi1HcWVXOG9Na2l0QjdTaTdGNHlYS0FQMG9KSndSMFRqSzRVc0ZJdVRweHRn?oc=5",
        "imagepath": "",
        "date": "2026-07-21 17:59:48",
        "description": "Granules Q1 net up 60% at 180 crore  BusinessLine..."
      },
      {
        "title": "Granules India records 60% YoY increase in Q1 PAT",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-21 16:04:01",
        "description": "Granules India records 60% YoY increase in Q1 PAT  Business Standard..."
      },
      {
        "title": "Granules India gets sole first-to-file status for narcolepsy drug Lumryz",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 12:13:15",
        "description": "Granules India gets sole first-to-file status for narcolepsy drug Lumryz  Business Standard..."
      },
      {
        "title": "Granules India gains after securing sole first-to-file ANDA status for LUMRYZ generic",
        "link": "https://news.google.com/rss/articles/CBMi-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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 12:05:11",
        "description": "Granules India gains after securing sole first-to-file ANDA status for LUMRYZ generic  Business Standard..."
      },
      {
        "title": "Granules India gets key US advantage for Generic Lumryz Tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 10:24:55",
        "description": "Granules India gets key US advantage for Generic Lumryz Tablets  BusinessLine..."
      },
      {
        "title": "Granules India gets key US advantage for Generic Lumryz Tablets",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 10:24:55",
        "description": "Granules India gets key US advantage for Generic Lumryz Tablets  BusinessLine..."
      },
      {
        "title": "Granules India secures FTF status for Sodium Oxybate ER for Oral Suspension ANDA",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-07-06 09:51:01",
        "description": "Granules India secures FTF status for Sodium Oxybate ER for Oral Suspension ANDA  Business Standard..."
      }
    ],
    "total": 7,
    "sid": "580033",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/granules-india-580033"
  },
  "announcements": [
    {
      "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
      "datetime": "06-Aug-2026",
      "details": "Scrutinizers report for the 35th AGM",
      "source": "BSE"
    },
    {
      "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
      "datetime": "06-Aug-2026",
      "details": "Outcome of 35th Annual General Meeting of the Company",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "04-Aug-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Life Insurance Corporation of India",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has declared <strong>175%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Granules India Ltd has announced <strong>1:10</strong> stock split, ex-date: 23 Mar 15",
          "dt": "2015-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Shareholder Meeting / Postal Ballot-Scrutinizers Report

06-Aug-2026 | Source : BSE

Scrutinizers report for the 35th AGM

Shareholder Meeting / Postal Ballot-Outcome of AGM

06-Aug-2026 | Source : BSE

Outcome of 35th Annual General Meeting of the Company

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

04-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Life Insurance Corporation of India

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Granules India Ltd has declared 175% dividend, ex-date: 30 Jul 26

stock-summary
SPLITS

Granules India Ltd has announced 1:10 stock split, ex-date: 23 Mar 15

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available